Spinzer Pharmaceuticals Private Limited
About Spinzer Pharmaceuticals Private Limited
Data last updated:
Spinzer Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Lark Laboratories (India) Ltd. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 April 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1983PTC015530.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Lark Cosmed Private Limited. It is led by directors including Kamal Prabha Anand and Beena Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 105/2 Okhla Industrial Areaphase – II, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2024, the company reported a revenue of ₹20,988, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹3,608 (net margin 17.2%) and EBITDA of -₹213 (EBITDA margin -1%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 20% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 105/2 Okhla Industrial Areaphase – II, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Spinzer Pharmaceuticals Private Limited
The main business activity of Spinzer Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Spinzer Pharmaceuticals Private Limited FY 2025 filings available
Spinzer Pharmaceuticals Private Limited reported revenue of ₹20,988 (down 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Spinzer Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 5% fall in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Spinzer Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹213 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3,608 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Spinzer Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 17.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Spinzer Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Spinzer Pharmaceuticals Private Limited
Spinzer Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SK Habib Pharmaceuticals Private Limited | ₹21,494 (FY 2025) | •••• | •••• | -67.0% | •••• | Kolkata, West Bengal, India |
| Sarvi Pharmaceuticals Private Limited | ₹21,450 (FY 2024) | •••• | •••• | -57.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| By Hanna Brand Solutions Private Limited | ₹21,430 (FY 2025) | •••• | •••• | -100.0% | •••• | Mumbai, Maharashtra, India |
| Zephyros Pharmaceuticals Private Limited | ₹21,190 (FY 2024) | •••• | •••• | -98.0% | •••• | Chandigarh, India |
| Mazhai Natural Farming and Food Processing Private Limited | ₹21,000 (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Spinzer Pharmaceuticals Private Limited this company | ₹20,988 (FY 2024) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
| Cyno Pharmaceuticals Limited | ₹20,960 (FY 2024) | •••• | •••• | •••• | Bharatpur, Rajasthan, India | |
| Accord Drugstore Private Limited | ₹20,725 (FY 2022) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Biocius Pharmaceuticals Private Limited | ₹20,469 (FY 2025) | •••• | •••• | -58.0% | •••• | Harinagar, Delhi, India |
| Medivast Pharmatech Private Limited | ₹20,420 (FY 2023) | •••• | •••• | •••• | Secunderabad, Telangana, India | |
| Natural Fit Lifecare Private Limited | ₹20,278 (FY 2019) | •••• | •••• | -93.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Spinzer Pharmaceuticals by revenue in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Spinzer Pharmaceuticals Private Limited
Spinzer Pharmaceuticals Private Limited is audited by GSSV & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GSSV & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Spinzer Pharmaceuticals Private Limited
Spinzer Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Prabha Anand Also directs: Lark Laboratories (India) Ltd | Director | 27 Aug 2012 | 14 Years 1 Months | Current |
| Beena Gupta | Director | 30 Aug 1997 | 29 Years 1 Months | Current |
| Viney Uppal Also directs: Gaurav Global LLP, Delite Electroplating Company LLP, Richaco Exports Private Limited and 4 more | Director | 11 Apr 1983 | 43 Years 5 Months | Current |
Ownership and Shareholding of Spinzer Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Spinzer Pharmaceuticals Private Limited
Spinzer Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Spinzer Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Spinzer Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Spinzer Pharmaceuticals Private Limited
Spinzer Pharmaceuticals Private Limited has 4 board changes on record since 1983: 3 appointments and 1 cessation. The latest: Kamal Prabha Anand ceased to be Additional Director on 28 Sep 2012.
Credit Ratings, Litigation & Regulatory Alerts for Spinzer Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Spinzer Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Spinzer Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Spinzer Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Spinzer Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spinzer Pharmaceuticals Private Limited
Spinzer Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 April 1983 (43+ years old) and is registered under CIN U74899DL1983PTC015530.
Spinzer Pharmaceuticals reported revenue of ₹20,988 for FY 2024 (down 5% YoY).
Spinzer Pharmaceuticals has 3 current directors:
- Kamal Prabha Anand - Director
- Beena Gupta - Director
- Viney Uppal - Director
Spinzer Pharmaceuticals reported a net profit of ₹3,608 (net margin 17.2%) and EBITDA of -₹213 (EBITDA margin -1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Spinzer Pharmaceuticals is -21% over three years and -20% over five years. In the latest year (FY 2024) revenue fell 5%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Spinzer Pharmaceuticals is U74899DL1983PTC015530. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spinzer Pharmaceuticals was incorporated on 08 April 1983, making it 43+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Spinzer Pharmaceuticals by revenue are SK Habib Pharmaceuticals Private Limited, Sarvi Pharmaceuticals Private Limited, By Hanna Brand Solutions Private Limited, Zephyros Pharmaceuticals Private Limited, Mazhai Natural Farming and Food Processing Private Limited and 5 more, all in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals).
Kamal Prabha Anand ceased to be Additional Director on 28 Sep 2012. Kamal Prabha Anand was appointed as Director on 27 Aug 2012. Beena Gupta was appointed as Director on 30 Aug 1997. Spinzer Pharmaceuticals has 4 board changes on record in total.
The registered office of Spinzer Pharmaceuticals is at A – 1052 Okhla Industrial Areaphase – II, New Delhi, Delhi, India – 110020.
Spinzer Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.